HUP0101614A2 - Biotin-kötő receptor molekulák - Google Patents

Biotin-kötő receptor molekulák

Info

Publication number
HUP0101614A2
HUP0101614A2 HU0101614A HUP0101614A HUP0101614A2 HU P0101614 A2 HUP0101614 A2 HU P0101614A2 HU 0101614 A HU0101614 A HU 0101614A HU P0101614 A HUP0101614 A HU P0101614A HU P0101614 A2 HUP0101614 A2 HU P0101614A2
Authority
HU
Hungary
Prior art keywords
biotin
receptor molecules
binding receptor
subject
target site
Prior art date
Application number
HU0101614A
Other languages
English (en)
Inventor
Kari Airenne
Markku Kulomaa
Pauliina Lehtolainen
Varpu Marjomaki
Seppo Yla-Herttuala
Original Assignee
Eurogene Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9803757.5A external-priority patent/GB9803757D0/en
Priority claimed from GBGB9813653.4A external-priority patent/GB9813653D0/en
Application filed by Eurogene Limited filed Critical Eurogene Limited
Publication of HUP0101614A2 publication Critical patent/HUP0101614A2/hu
Publication of HUP0101614A3 publication Critical patent/HUP0101614A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya membrán-feszítő domént és exracelluláris doménttartalmazó fehérje, melyben az extracelluláris domén biotinkötőaktivitást tartalmaz. A találmány tárgyához tartozik továbbá amegfelelő fehérje-előállítási eljárás, valamint a biotinilezettmolekula alkalmazása a célhelyre bejuttatható gyógyszer előállítására,mely célhely az 1-5. igénypontok bármelyike szerinti fehérjéttartalmazza. Ó
HU0101614A 1998-02-23 1999-02-23 Biotin-binding receptor molecules HUP0101614A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9803757.5A GB9803757D0 (en) 1998-02-23 1998-02-23 Fusion proteins
GBGB9813653.4A GB9813653D0 (en) 1998-06-24 1998-06-24 Fusion proteins
PCT/GB1999/000546 WO1999042577A2 (en) 1998-02-23 1999-02-23 Biotin-binding receptor molecules

Publications (2)

Publication Number Publication Date
HUP0101614A2 true HUP0101614A2 (hu) 2001-09-28
HUP0101614A3 HUP0101614A3 (en) 2006-04-28

Family

ID=26313170

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101614A HUP0101614A3 (en) 1998-02-23 1999-02-23 Biotin-binding receptor molecules

Country Status (16)

Country Link
US (1) US7208291B2 (hu)
EP (1) EP1056850B1 (hu)
JP (1) JP2002504328A (hu)
KR (1) KR100722578B1 (hu)
CN (1) CN1195852C (hu)
AT (1) ATE274058T1 (hu)
AU (1) AU750444B2 (hu)
CA (1) CA2319039A1 (hu)
DE (1) DE69919515T2 (hu)
DK (1) DK1056850T3 (hu)
ES (1) ES2226340T3 (hu)
HU (1) HUP0101614A3 (hu)
NO (1) NO328139B1 (hu)
PL (1) PL195990B1 (hu)
PT (1) PT1056850E (hu)
WO (1) WO1999042577A2 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040209294A1 (en) * 2002-09-02 2004-10-21 National Food Research Institute Method to produce a receptor chip using biotinylated protein
US9623117B2 (en) * 2011-04-04 2017-04-18 Wisconsin Alumni Research Foundation Method for selective targeting and entry of bacterial toxins to cells
SG10201804439PA (en) * 2013-12-20 2018-06-28 Hutchinson Fred Cancer Res Tagged chimeric effector molecules and receptors thereof
EP3288570A4 (en) 2015-04-29 2018-11-21 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839293A (en) * 1986-02-24 1989-06-13 The Trustees Of Columbia University In The City Of New York DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
CA1340977C (en) * 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5457035A (en) * 1993-07-23 1995-10-10 Immunex Corporation Cytokine which is a ligand for OX40
US5846537A (en) 1995-06-07 1998-12-08 University Of Rochester Modified avidin and streptavidin and methods of use thereof
US6497881B1 (en) * 1995-11-30 2002-12-24 New York University High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein

Also Published As

Publication number Publication date
DE69919515T2 (de) 2005-04-07
HUP0101614A3 (en) 2006-04-28
PL195990B1 (pl) 2007-11-30
JP2002504328A (ja) 2002-02-12
CN1195852C (zh) 2005-04-06
KR20010085196A (ko) 2001-09-07
EP1056850A2 (en) 2000-12-06
EP1056850B1 (en) 2004-08-18
CN1291230A (zh) 2001-04-11
DK1056850T3 (da) 2004-11-29
AU750444B2 (en) 2002-07-18
US20040185059A1 (en) 2004-09-23
PL343079A1 (en) 2001-07-30
NO20004195L (no) 2000-08-22
AU2631299A (en) 1999-09-06
NO328139B1 (no) 2009-12-14
WO1999042577A3 (en) 1999-10-21
CA2319039A1 (en) 1999-08-26
ATE274058T1 (de) 2004-09-15
KR100722578B1 (ko) 2007-05-28
PT1056850E (pt) 2004-12-31
DE69919515D1 (de) 2004-09-23
ES2226340T3 (es) 2005-03-16
NO20004195D0 (no) 2000-08-22
WO1999042577A2 (en) 1999-08-26
US7208291B2 (en) 2007-04-24

Similar Documents

Publication Publication Date Title
CY1120384T1 (el) Απταμερη θεραπευτικα χρησιμα στην αντιμετωπιση των σχετικων με το συμπληρωμα διαταραχων
CY1118299T1 (el) Ανοσοκατασταλτικες ενωσεις και συνθεσεις
CY1112505T1 (el) Ανοσοκατασταλτικες ενωσεις και συνθεσεις
CY1115059T1 (el) Θεραπευτικα απταμερη χρησιμα στην θεραπευτικη αγωγη διαταραχων σχετιζομενων με συμπληρωμα
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
NO20053855L (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
TR200201094T2 (tr) Farmasötik maddeler olarak bisiklik amino asitler
CY1106032T1 (el) Υποκατασταθεισες πυραζολες
MXPA05003591A (es) Materiales basados en ciclodextrina, composiciones y usos relacionados a los mismos.
DE602004000260D1 (de) Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
GB0222495D0 (en) Compounds
DE602006020501D1 (de) Synthetische mecp2-sequenz für die proteinersatztherapie
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
NO20090348L (no) Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
PT1060175E (pt) Inibidores de triptase
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
DE60326069D1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
BR0008292A (pt) Derivados de mevinolina
DE60025639D1 (de) Substituierte diazepan
HUP0101614A2 (hu) Biotin-kötő receptor molekulák
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ARK THERAPEUTICS LIMITED, GB

Free format text: FORMER OWNER(S): EUROGENE LIMITED, GB

FC4A Lapse of provisional application due to refusal